Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease

press
Written By Jessica Sagers

Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt University’s innovative life science research, will fund further research into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves. This is the third Vanderbilt project Ancora has funded.

Jessica Sagers
Previous

Vanderbilt-Ancora partnership advances research for rare form of epilepsy
Next

Deerfield Management and Vanderbilt University announce the launch of Ancora Innovation